Ganciclovir prophylaxis of cytomegalovirus disease

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 804-806

  Conti, D J ^a   Shen, G ^a   Singh, T ^a   Isenberg, A ^a   Freed, B M ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; LYMPHOCYTE ANTIBODY;

ADULT; ARTHRALGIA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS;

ADULT; ANTIVIRAL AGENTS; COSTS AND COST ANALYSIS; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; GANCICLOVIR; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MUROMONAB-CD3; NEW YORK; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL RATE;

EID: 0030951126     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00141-8     Document Type: Conference Paper

References (10)

1. Rubin RH, Tolkoff-Rubin NE: Antimicrob Agents Chemother 37:619, 1993
2. Rubin RH, Tolkoff-Rubin NE: Transplant Proc 23:2068, 1991
3. van Dorp WT, van Wieringen PAM, Marselig-Jonges E, et al: Transplantation 55:1367, 1993
4. Gaston JSH, Waer M: Immunol Today 8:237, 1985
5. Snydman DR: Transplant Rev 4:59, 1990
6. Ho M, Suwansirikul S, Dowling JN, et al: N Engl J Med 293:1109, 1975
7. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al: Transplantation 53:63, 1992
8. Hibberd PL, Rubin RH, Conti DJ, et al: Ann Int Med 123:18, 1995
9. Weir MR, Henry ML, Blackmore M, et al: Transplantation 45:11, 1988
10. Snydman DR, Werner BG, Heinze-Lacey B, et al: N Engl J Med 317:1049, 1987